Americans prefer drugs for depression, survey finds

WASHINGTON, June 1 Tue Jun 1, 2010 6:00am EDT

WASHINGTON, June 1 (Reuters) - Americans prefer drugs to talk therapy for depression, with nearly 80 percent taking a pill for the condition, Consumer Reports said on Tuesday.

The most popular class of drugs remain the so-called SSRIs such as Prozac, the group found. People found newer, pricier antidepressants less desirable because of side-effects.

Patients benefited just as much from therapy -- almost any kind of therapy, the consumer group found in its survey of 1,500 readers.

Those surveyed said they improved just as much after seven or more sessions of talk therapy as if they took drugs and it did not matter if the therapist was a psychiatrist, psychologist or social worker.

Nearly 80 percent of people who had been diagnosed with depression or anxiety were prescribed antidepressants.

Patients were happiest with the selective serotonin reuptake inhibitors or SSRIs, a class that includes Eli Lilly and Co's (LLY.N) Prozac or its generic equivalent fluoxetine;, Pfizer Inc's (PFE.N) Zoloft or sertraline, and Celexa or citalopram and Lexapro o escitalopram from Forest Laboratories Inc FRX.N.

People complained of more side-effects from serotonin-norepinephrine reuptake inhibitors or SNRIs, a newer, often more expensive class of antidepressants, the survey found.

These include venlafaxine, made by Pfizer-owned (PFE.N) Wyeth under the Effexor brand name and Lilly's duloxetine, sold as Cymbalta.

The survey found a range of side-effects, but the most common one -- loss of sexual interest or ability -- was less common than in past surveys, the consumer group said.

FILED UNDER:
We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of Reuters. For more information on our comment policy, see http://blogs.reuters.com/fulldisclosure/2010/09/27/toward-a-more-thoughtful-conversation-on-stories/
Comments (13)
DanielHaszard wrote:
Psychotropic meds are indicated for true clinical conditions.
I was prescribed Eli Lilly Zyprexa by my physician *off-label* for PTSD and it was all wrong,cost me a lot of money and the side effects damaged my pancreas and gave me life-long diabetes.
Daniel Haszard

Jun 01, 2010 6:45am EDT  --  Report as abuse
DanielHaszard wrote:
Eli Lilly has made $40 billion on $10 dollar a pill Zyprexa and it was way oversold and caused diabetes and in some cases sudden death. Zyprexa was pushed by Lilly Drug Reps.

They called it the “Five at Five” (5 mg at 5 pm to keep nursing home patients subdued and sleepy) and “VIVA ZYPREXA” (Zyprexa for everybody) campaigns to off label market Eli Lilly Zyprexa as a fix for unapproved usage.

Jun 01, 2010 6:46am EDT  --  Report as abuse
It’s too bad the majority of people aren’t aware of tools that WORK, or help to treat the actual cause of their condition.

Jun 01, 2010 10:08am EDT  --  Report as abuse
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.